Validity and reliability of the Turkish version of the DSM-5 Generalized Anxiety Disorder Severity Scale for children aged 11–17 years

Validity and reliability of the Turkish version of the DSM-5 Generalized Anxiety Disorder Severity Scale for children aged 11–17 years

Background/aim: This study aimed to assess the validity and reliability of the Turkish version of the DSM-5 Generalized AnxietyDisorder Severity Scale - Child Form.Materials and methods: The study sample consisted of 32 patients treated in a child psychiatry unit and diagnosed with generalizedanxiety disorder and 98 healthy volunteers who were attending middle or high school during the study period. For the assessment,the Screen for Child Anxiety and Related Emotional Disorders (SCARED) was also used along with the DSM-5 Generalized AnxietyDisorder Severity Scale - Child Form.Results: Regarding reliability analyses, the Cronbach alpha internal consistency coefficient was calculated as 0.932. The test–retestcorrelation coefficient was calculated as r = 0.707. As for construct validity, one factor that could explain 62.6% of the variance wasobtained and this was consistent with the original construct of the scale. As for concurrent validity, the scale showed a high correlationwith SCARED.Conclusion: It was concluded that Turkish version of the DSM-5 Generalized Anxiety Disorder Severity Scale - Child Form could beutilized as a valid and reliable tool both in clinical practice and for research purposes.

___

  • Costello EJ, Egger HL, Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 2005; 14: 631-648.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC, USA: American Psychiatric Association; 2013.
  • Keeton CP, Kolos AC, Walkup CT. Pediatric generalized anxiety disorder epidemiology, diagnosis, and management. Pediatr Drugs 2009; 11: 171-183.
  • Verona E, Javdani S. Dimensions of adolescent psychopathology and relationships to suicide risk indicators. J Youth Adolesc 2011; 40: 958-971.
  • Drake KL, Ginsburg GS. Family factors in the development, treatment, and prevention of childhood anxiety disorders. Clin Child Fam Psychol Rev 2012; 15: 144-162.
  • Scharfstein L, Alfano C, Beidel D, Wong N. Children with generalized anxiety disorder do not have peer problems, just fewer friends. Child Psychiatry Hum Dev 2011; 42: 712-723.
  • Zehe JM, Colder CR, Read JP, Wieczorek WF, Lengua LJ. Social and generalized anxiety symptoms and alcohol and cigarette use in early adolescence: the moderating role of perceived peer norms. Addict Behav 2013; 38: 1931-1939.
  • Chavira DA, Stein MB, Bailey K, Stein MT. Child anxiety in primary care: prevalent but untreated. Depress Anxiety 2004; 20: 155-164.
  • Connolly SD, Suarez L, Sylvester C. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep 2011; 13: 99-110.
  • March JS, Parker JDA, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 554-565.
  • Birmaher B, Brent DA, Chiapetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 1999; 38: 1230-1236.
  • Spence SH, Barrett PM, Turner CM. Psychometric properties of the Spence Children’s Anxiety Scale with young adolescents. J Anxiety Disord 2003; 17: 605-625.
  • [No authors listed.] The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002; 41: 1061-1069.
  • Desousa DA, Salum GA, Isolan LR, Manfro GG. Sensitivity and specificity of the screen for child anxiety related emotional disorders (SCARED): a community-based study. Child Psychiatry Hum Dev 2013; 44: 391-399.
  • Villabø M, Gere M, Torgersen S, March JS, Kendall PC. Diagnostic efficiency of the child and parent versions of the Multidimensional Anxiety Scale for Children. J Clin Child Adolesc Psychol 2012; 41: 75-85.
  • LeBeau RT, Glenn DE, Hanover LN, Beesdo-Baum K, Wittchen HU, Craske MG. A dimensional approach to measuring anxiety for DSM-5. Int J Methods Psychiatr Res 2012; 21: 258-272.
  • American Psychiatric Association. “Online Assessment Measures”. Washington, DC, USA: American Psychiatric Association; 2017.
  • Möller EL, Majdandzic M, Craske MG, Bögels SM. Dimensional assessment of anxiety disorders in parents and children for DSM-5. Int J Methods Psychiatr Res 2014; 23: 331-344.
  • Tavşancıl E. Tutumların Ölçülmesi ve SPSS ile Veri Analizi, Ankara, Turkey: Nobel Yayın Dağıtım; 2006 (in Turkish).
  • Çakmakçı FK. Çocuklarda anksiyete bozukluklarını tarama ölçeği geçerlik ve güvenirlik çalışması. Expertise thesis, Kocaeli University, Kocaeli, Turkey, 2004 (in Turkish).
  • Aydemir Ö, Köroğlu E. Psikiyatride Kullanılan Klinik Ölçekler. Ankara, Turkey: Hekimler Yayın Birliği; 2000 (in Turkish).
  • Essau CA, Petermann F. Anxiety Disorders in Children and Adolescents: Epidemiology, Risk Factors and Treatment. London, UK: Routledge; 2013.
  • Gormez V, Kilincaslan A, Orengul AC, Ebesutani C, Kaya I, Ceri V, Nasiroglu S, Filiz M, Chorpita B. Psychometric properties of the Turkish translation of the Revised Child Anxiety and Depression Scale- Child Version (RCADS-CV) in a clinical sample. Psychiatry and Clinical Psychopharmacology 2017; 27: 84-92.